Taken together, this is the first study to simultaneously quantify tau protein isoforms, non-phosphorylated and phosphorylated tau protein in both TBS and SI fractions from different tauopathies, specifically AD, PSP, CBD, and PiD, and control cases. This evidence concerns the gene MAPT and tauopathy.